-+ 0.00%
-+ 0.00%
-+ 0.00%

VESICOR THERAPEUTICS, INC. AND BLACK HAWK ACQUISITION CORPORATION ENTER INTO A BUSINESS COMBINATION AGREEMENT TO CREATE A BIOTECHNOLOGY COMPANY ADVANCING P53-BASED CANCER THERAPEUTICS DELIVERED VIA MICROVESICLES

Reuters·04/28/2025 21:30:00

Please log in to view news